Taliglucerase alfa regulatory update

Pfizer submitted an MAA to the European Medicines Agency (EMA) for taliglucerase alfa to treat Gaucher's disease. An NDA for the plant cell-expressed recombinant form of human glucocerebrosidase (GCase) is under FDA review with a Feb. 25, 2011, PDUFA date. ...